Business

Neurocrine Biosciences sold $53 million of CRENESSITY in the second quarter of 2025. A year later, the same drug brought in $184 million, and a second rare-disease product, acquired in May, added $54 million in…

Growth is visible after the foundations are already doing their job. A site begins to look stronger when pages move, impressions rise and better enquiries arrive, but the work that makes those outcomes possible is…